Overcoming Supply Chain Roadblocks To Ensure Reliable Complex OSD Delivery

Pfizer CentreOne's Ascoli site successfully delivered complex oral solid dosage (OSD) therapeutics by overcoming supply chain obstacles. Despite facing a technical challenge that caused a loss of visibility of demand signals, the Ascoli site maintained on-time in-full (OTIF) delivery rate of over 90%.

In 2020, a global pharmaceutical client, formed by the merger of two predecessor companies, relied on the Ascoli site for the production of OSD medications. However, in 2022, as it became a separate legal entity, the client faced a challenge and had to separate from services acquired from the predecessor companies, resulting in the client's supply chain management platform being inactive for a month. To overcome this, the Ascoli site implemented a proactive approach to stock-building activities and accurately planned to meet demand. Effective communication with the client and continuous evaluation and adjustment of strategies played a crucial role in ensuring a reliable supply of complex OSDs.